PHARMACEUTICAL COMPOSITION FOR TREATING GASTRO-OESOPHAGEAL REFLUX DISEASE

摘要

The invention relates to the pharmaceutical industry and provides a pharmaceutical composition for treatment of gastroesophageal reflux disease, the said composition consisting of at least one proton pump inhibitor and at least one prebiotic, while the content of the proton pump inhibitor in the composition is 0.05 to 0.25% w/w, prebiotic - 10 to 95% w/w and excipients - up to 100% w/w. The invention ensures prevention of translocation of H. pylori, eliminates the need to detect H. pylori and conduct bacteria eradication treatment, improves the security of long-term therapy with proton pump inhibitors and avoids atrophy of gastric mucosa and the risk of development of gastric cancer. 2 primary claims and 3 subordinate claims, 10 tables.